53 related articles for article (PubMed ID: 23477400)
1. Implications of multipotent mesenchymal stromal cell aging.
Stochaj U; Kodiha M; Shum-Tim D; Colmegna I
Regen Med; 2013 Mar; 8(2):211-22. PubMed ID: 23477400
[TBL] [Abstract][Full Text] [Related]
2. A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects.
Zhang J; Lian Q; Zhu G; Zhou F; Sui L; Tan C; Mutalif RA; Navasankari R; Zhang Y; Tse HF; Stewart CL; Colman A
Cell Stem Cell; 2011 Jan; 8(1):31-45. PubMed ID: 21185252
[TBL] [Abstract][Full Text] [Related]
3. Towards a Drosophila model of Hutchinson-Gilford progeria syndrome.
Beard GS; Bridger JM; Kill IR; Tree DR
Biochem Soc Trans; 2008 Dec; 36(Pt 6):1389-92. PubMed ID: 19021561
[TBL] [Abstract][Full Text] [Related]
4. Aging and nuclear organization: lamins and progeria.
Mounkes LC; Stewart CL
Curr Opin Cell Biol; 2004 Jun; 16(3):322-7. PubMed ID: 15145358
[TBL] [Abstract][Full Text] [Related]
5. Aging of Hutchinson-Gilford progeria syndrome fibroblasts is characterised by hyperproliferation and increased apoptosis.
Bridger JM; Kill IR
Exp Gerontol; 2004 May; 39(5):717-24. PubMed ID: 15130666
[TBL] [Abstract][Full Text] [Related]
6. In vitro pathological modelling using patient-specific induced pluripotent stem cells: the case of progeria.
Nissan X; Blondel S; Peschanski M
Biochem Soc Trans; 2011 Dec; 39(6):1775-9. PubMed ID: 22103524
[TBL] [Abstract][Full Text] [Related]
7. Hutchinson-Gilford progeria syndrome alters nuclear shape and reduces cell motility in three dimensional model substrates.
Booth-Gauthier EA; Du V; Ghibaudo M; Rape AD; Dahl KN; Ladoux B
Integr Biol (Camb); 2013 Mar; 5(3):569-77. PubMed ID: 23370891
[TBL] [Abstract][Full Text] [Related]
8. Hutchinson-Gilford progeria syndrome through the lens of transcription.
Prokocimer M; Barkan R; Gruenbaum Y
Aging Cell; 2013 Aug; 12(4):533-43. PubMed ID: 23496208
[TBL] [Abstract][Full Text] [Related]
9. A progeroid syndrome in mice is caused by defects in A-type lamins.
Mounkes LC; Kozlov S; Hernandez L; Sullivan T; Stewart CL
Nature; 2003 May; 423(6937):298-301. PubMed ID: 12748643
[TBL] [Abstract][Full Text] [Related]
10. N6-isopentenyladenosine improves nuclear shape in fibroblasts from humans with progeroid syndromes by inhibiting the farnesylation of prelamin A.
Bifulco M; D'Alessandro A; Paladino S; Malfitano AM; Notarnicola M; Caruso MG; Laezza C
FEBS J; 2013 Dec; 280(23):6223-32. PubMed ID: 24112551
[TBL] [Abstract][Full Text] [Related]
11. Adipose-derived mesenchymal stem cells and regenerative medicine.
Konno M; Hamabe A; Hasegawa S; Ogawa H; Fukusumi T; Nishikawa S; Ohta K; Kano Y; Ozaki M; Noguchi Y; Sakai D; Kudoh T; Kawamoto K; Eguchi H; Satoh T; Tanemura M; Nagano H; Doki Y; Mori M; Ishii H
Dev Growth Differ; 2013 Apr; 55(3):309-18. PubMed ID: 23452121
[TBL] [Abstract][Full Text] [Related]
12. Unique preservation of neural cells in Hutchinson- Gilford progeria syndrome is due to the expression of the neural-specific miR-9 microRNA.
Nissan X; Blondel S; Navarro C; Maury Y; Denis C; Girard M; Martinat C; De Sandre-Giovannoli A; Levy N; Peschanski M
Cell Rep; 2012 Jul; 2(1):1-9. PubMed ID: 22840390
[TBL] [Abstract][Full Text] [Related]
13. Regenerative cells for transplantation in hepatic failure.
Ishikawa T; Banas A; Teratani T; Iwaguro H; Ochiya T
Cell Transplant; 2012; 21(2-3):387-99. PubMed ID: 22793046
[TBL] [Abstract][Full Text] [Related]
14. Genome-scale expression profiling of Hutchinson-Gilford progeria syndrome reveals widespread transcriptional misregulation leading to mesodermal/mesenchymal defects and accelerated atherosclerosis.
Csoka AB; English SB; Simkevich CP; Ginzinger DG; Butte AJ; Schatten GP; Rothman FG; Sedivy JM
Aging Cell; 2004 Aug; 3(4):235-43. PubMed ID: 15268757
[TBL] [Abstract][Full Text] [Related]
15. Does aging of mesenchymal stem cells limit their potential application in clinical practice?
Bajek A; Czerwinski M; Olkowska J; Gurtowska N; Kloskowski T; Drewa T
Aging Clin Exp Res; 2012 Oct; 24(5):404-11. PubMed ID: 22595834
[TBL] [Abstract][Full Text] [Related]
16. Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition.
Glynn MW; Glover TW
Hum Mol Genet; 2005 Oct; 14(20):2959-69. PubMed ID: 16126733
[TBL] [Abstract][Full Text] [Related]
17. Concise review: multipotent mesenchymal stromal cells in blood.
He Q; Wan C; Li G
Stem Cells; 2007 Jan; 25(1):69-77. PubMed ID: 16973831
[TBL] [Abstract][Full Text] [Related]
18. Human inferior turbinate: an alternative tissue source of multipotent mesenchymal stromal cells.
Hwang SH; Kim SY; Park SH; Choi MY; Kang HW; Seol YJ; Park JH; Cho DW; Hong OK; Rha JG; Kim SW
Otolaryngol Head Neck Surg; 2012 Sep; 147(3):568-74. PubMed ID: 22588732
[TBL] [Abstract][Full Text] [Related]
19. Vascular aging: insights from studies on cellular senescence, stem cell aging, and progeroid syndromes.
Minamino T; Komuro I
Nat Clin Pract Cardiovasc Med; 2008 Oct; 5(10):637-48. PubMed ID: 18762784
[TBL] [Abstract][Full Text] [Related]
20. The Hutchinson-Gilford Progeria Syndrome: a case report.
Russo-Menna I; Arancibias C
Minerva Anestesiol; 2010 Feb; 76(2):151-4. PubMed ID: 20150858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
